Preliminary experience with quality of life evaluation in patients with lung cancer.

2.50
Hdl Handle:
http://hdl.handle.net/10541/107650
Title:
Preliminary experience with quality of life evaluation in patients with lung cancer.
Authors:
Hopwood, Penelope; Thatcher, Nick
Abstract:
Evaluating quality of life in patients receiving treatment for cancer has been an increasing concern, particularly when a cure may not be possible. Such measurements inform clinicians and investigators of the relative costs and benefits of palliative treatments, and are potentially important when there is little or no difference between drug regimens in terms of tumor response or survival. Where it is felt intuitively by oncologists that a particular mode or frequency of therapy may be superior to existing regimens, quality of life data may inform us differently, and there is a case to be made for incorporating such evaluations in clinical trials. In parallel to the experience of other groups, we have developed experience with certain scales, focusing on evaluations of lung cancer patients. This process enabled us to prospectively include and implement quality of life studies into our clinical trials.
Affiliation:
Christie Hospital and Holt Radium Institute, Manchester, UK.
Citation:
Preliminary experience with quality of life evaluation in patients with lung cancer. 1990, 4 (5):158-62; discussion 171 Oncology
Journal:
Oncology
Issue Date:
May-1990
URI:
http://hdl.handle.net/10541/107650
PubMed ID:
2166550
Type:
Article
Language:
en
ISSN:
0890-9091
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorHopwood, Penelopeen
dc.contributor.authorThatcher, Nicken
dc.date.accessioned2010-07-14T16:19:19Z-
dc.date.available2010-07-14T16:19:19Z-
dc.date.issued1990-05-
dc.identifier.citationPreliminary experience with quality of life evaluation in patients with lung cancer. 1990, 4 (5):158-62; discussion 171 Oncologyen
dc.identifier.issn0890-9091-
dc.identifier.pmid2166550-
dc.identifier.urihttp://hdl.handle.net/10541/107650-
dc.description.abstractEvaluating quality of life in patients receiving treatment for cancer has been an increasing concern, particularly when a cure may not be possible. Such measurements inform clinicians and investigators of the relative costs and benefits of palliative treatments, and are potentially important when there is little or no difference between drug regimens in terms of tumor response or survival. Where it is felt intuitively by oncologists that a particular mode or frequency of therapy may be superior to existing regimens, quality of life data may inform us differently, and there is a case to be made for incorporating such evaluations in clinical trials. In parallel to the experience of other groups, we have developed experience with certain scales, focusing on evaluations of lung cancer patients. This process enabled us to prospectively include and implement quality of life studies into our clinical trials.en
dc.language.isoenen
dc.subjectLung Canceren
dc.subject.meshCarcinoma, Non-Small-Cell Lung-
dc.subject.meshEvaluation Studies as Topic-
dc.subject.meshFemale-
dc.subject.meshHumans-
dc.subject.meshLung Neoplasms-
dc.subject.meshMale-
dc.subject.meshPsychological Tests-
dc.subject.meshQuality of Life-
dc.titlePreliminary experience with quality of life evaluation in patients with lung cancer.en
dc.typeArticleen
dc.contributor.departmentChristie Hospital and Holt Radium Institute, Manchester, UK.en
dc.identifier.journalOncologyen
All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.